这是一篇来自已证抗体库的有关
人类 DR5的综述，是根据29篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合DR5 抗体。
DR5 同义词: CD262; DR5; KILLER; KILLER/DR5; TRAIL-R2; TRAILR2; TRICK2; TRICK2A; TRICK2B; TRICKB; ZTNFR9
BioLegend
| 小鼠 单克隆（DJR2-4 (7-8)） | | BioLegend DR5抗体（BioLegend, DJR2-4 (7-8))被用于被用于流式细胞仪在人类样本上 (图 s2g). Cell Death Dis (2019) ncbi |
| 小鼠 单克隆（DJR2-4 (7-8)） | | BioLegend DR5抗体（Biolegend, 307408)被用于被用于流式细胞仪在人类样本上 (图 1b, 1e). Front Immunol (2019) ncbi |
| 小鼠 单克隆（DJR2-4 (7-8)） | | BioLegend DR5抗体（BioLegend, 307402)被用于被用于其他在人类样本上浓度为500 ug/ml (图 1). J Extracell Vesicles (2016) ncbi |
| 小鼠 单克隆（DJR2-4 (7-8)） | | BioLegend DR5抗体（BioLegend, 307405)被用于被用于流式细胞仪在人类样本上 (图 4). PLoS ONE (2015) ncbi |
| 小鼠 单克隆（DJR2-4 (7-8)） | | BioLegend DR5抗体（Biolegend, DJR2-4)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2014) ncbi |
圣克鲁斯生物技术
| 小鼠 单克隆（B-D37） | | 圣克鲁斯生物技术 DR5抗体（Santa Cruz, sc-65314)被用于被用于免疫印迹在人类样本上 (图 2c). Breast Cancer Res (2019) ncbi |
| 小鼠 单克隆（D-6） | | 圣克鲁斯生物技术 DR5抗体（Santa Cruz, sc-166624)被用于被用于免疫印迹在人类样本上 (图 1c). J Biol Chem (2019) ncbi |
| 小鼠 单克隆（D-6） | | 圣克鲁斯生物技术 DR5抗体（Santa Cruz Biotechnology, SC-166624)被用于被用于免疫细胞化学在人类样本上浓度为1:200. Anticancer Drugs (2014) ncbi |
| 小鼠 单克隆（B-D37） | | 圣克鲁斯生物技术 DR5抗体（Santa Cruz Biotechnology, B-D37)被用于被用于免疫印迹在人类样本上. J Biol Chem (2011) ncbi |
安迪生物R&D
| 小鼠 单克隆（71903） | | 安迪生物R&D DR5抗体（R&D, mab631)被用于被用于流式细胞仪在人类样本上 (图 s7b). Cell (2019) ncbi |
| 小鼠 单克隆（71908） | | 安迪生物R&D DR5抗体（R&D Systems, FAB6311P)被用于被用于流式细胞仪在人类样本上 (图 5i). Mol Cancer Res (2017) ncbi |
| 小鼠 单克隆（71908） | | 安迪生物R&D DR5抗体（R&D Systems, FAB6311P)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi |
| 小鼠 单克隆（71908） | | 安迪生物R&D DR5抗体（R&D Systems, MAB6311)被用于被用于免疫组化-石蜡切片在人类样本上. Clin Breast Cancer (2015) ncbi |
| 小鼠 单克隆（71908） | | 安迪生物R&D DR5抗体（R&D Systems, 71908)被用于被用于流式细胞仪在人类样本上浓度为5 ug/ml. J Biol Chem (2011) ncbi |
艾博抗（上海）贸易有限公司
| domestic rabbit 单克隆 | | 艾博抗（上海）贸易有限公司 DR5抗体（Abcam, ab199357)被用于被用于免疫印迹在人类样本上 (图 4a). Arthritis Res Ther (2020) ncbi |
| 小鼠 单克隆（DR5-01-1） | | 艾博抗（上海）贸易有限公司 DR5抗体（Abcam, ab53319)被用于被用于流式细胞仪在人类样本上 (图 s5b). Cell (2019) ncbi |
赛默飞世尔
| 小鼠 单克隆（DJR2-4 (7-8)） | | 赛默飞世尔 DR5抗体（eBioscience, 12-9908-41)被用于被用于流式细胞仪在人类样本上 (图 4c). Cell Death Differ (2019) ncbi |
| 小鼠 单克隆（DJR2-4 (7-8)） | | 赛默飞世尔 DR5抗体（eBioscience, DJR2-4)被用于被用于流式细胞仪在人类样本上 (图 s2). BMC Biotechnol (2016) ncbi |
Enzo Life Sciences
| 小鼠 单克隆（DJR2-4） | | Enzo Life Sciences DR5抗体（Enzo life sciences, ALX-804-914-0100)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1). Oncotarget (2016) ncbi |
武汉三鹰
| domestic rabbit 多克隆 | | 武汉三鹰 DR5抗体（Proteintech, 15497-1-AP)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3d). Biochem Biophys Res Commun (2019) ncbi |
赛信通（上海）生物试剂有限公司
| domestic rabbit 单克隆（D4E9） | | 赛信通（上海）生物试剂有限公司 DR5抗体（CST, 8074)被用于被用于免疫印迹在人类样本上 (图 2a). Cell Death Dis (2020) ncbi |
| domestic rabbit 单克隆（D4E9） | | 赛信通（上海）生物试剂有限公司 DR5抗体（Cell Signaling Technology, 8074)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1s4c). elife (2020) ncbi |
| domestic rabbit 单克隆（D4E9） | | 赛信通（上海）生物试剂有限公司 DR5抗体（Cell Signaling Technology, 8074)被用于被用于免疫印迹在人类样本上 (图 2a). Sci Rep (2017) ncbi |
| domestic rabbit 多克隆 | | 赛信通（上海）生物试剂有限公司 DR5抗体（cell signalling, 3696)被用于被用于免疫印迹在人类样本上 (图 2b). EMBO J (2017) ncbi |
| domestic rabbit 单克隆（D4E9） | - 免疫印迹基因敲除验证; 人类; 1:1000; 图 9e
- 免疫细胞化学; 人类; 1:200; 图 2f
| 赛信通（上海）生物试剂有限公司 DR5抗体（Cell Signaling, D4E9)被用于被用于免疫印迹基因敲除验证在人类样本上浓度为1:1000 (图 9e) 和 被用于免疫细胞化学在人类样本上浓度为1:200 (图 2f). Mol Cell Biol (2017) ncbi |
| domestic rabbit 多克隆 | | 赛信通（上海）生物试剂有限公司 DR5抗体（cell signalling, 3696)被用于被用于免疫印迹在人类样本上 (图 s1). Mol Cell (2017) ncbi |
| domestic rabbit 单克隆（D4E9） | | 赛信通（上海）生物试剂有限公司 DR5抗体（Cell Signaling, 8074S)被用于被用于免疫印迹在人类样本上 (图 3a). Antioxid Redox Signal (2017) ncbi |
| domestic rabbit 单克隆（D4E9） | | 赛信通（上海）生物试剂有限公司 DR5抗体（Cell Signaling, 8074)被用于被用于免疫印迹在人类样本上 (图 2a). Int J Biochem Cell Biol (2017) ncbi |
| domestic rabbit 多克隆 | | 赛信通（上海）生物试剂有限公司 DR5抗体（Cell Signaling, 3696)被用于被用于免疫印迹在人类样本上 (图 2). J Biol Chem (2016) ncbi |
| domestic rabbit 单克隆（D4E9） | | 赛信通（上海）生物试剂有限公司 DR5抗体（Cell Signaling, 8074)被用于被用于免疫印迹在大鼠样本上 和 被用于免疫细胞化学在人类样本上. Toxicol Lett (2015) ncbi |
ATCC
| 小鼠 单克隆 | | ATCC DR5抗体（American Type Culture Collection, TIB200)被用于被用于免疫细胞化学在人类样本上. Bone (2006) ncbi |
Yang X, Guo Q, Feng T, Lu Q, Ge L, Pan J,
et al. IL13Rα1 protects against rheumatoid arthritis by combating the apoptotic resistance of fibroblast-like synoviocytes. Arthritis Res Ther. 2020;22:184
pubmed 出版商 Ding B, Yuan F, Damle P, Litovchick L, Drapkin R, Grossman S. CtBP determines ovarian cancer cell fate through repression of death receptors. Cell Death Dis. 2020;11:286
pubmed 出版商 Lam M, Marsters S, Ashkenazi A, Walter P. Misfolded proteins bind and activate death receptor 5 to trigger apoptosis during unresolved endoplasmic reticulum stress. elife. 2020;9:
pubmed 出版商 Chollat Namy M, Ben Safta Saadoun T, Haferssas D, Meurice G, Chouaib S, Thiery J. The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy. Cell Death Dis. 2019;10:695
pubmed 出版商 Staniek J, Lorenzetti R, Heller B, Janowska I, Schneider P, Unger S,
et al. TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes. Front Immunol. 2019;10:951
pubmed 出版商 Poondla N, Chandrasekaran A, Heese K, Kim K, Ramakrishna S. CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis. Biochem Biophys Res Commun. 2019;:
pubmed 出版商 Pan L, Fu T, Zhao W, Zhao L, Chen W, Qiu C,
et al. Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling. Cell. 2019;176:1477-1489.e14
pubmed 出版商 Greer Y, Gilbert S, Gril B, Narwal R, Peacock Brooks D, Tice D,
et al. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer. Breast Cancer Res. 2019;21:27
pubmed 出版商 Kim M, Song J, Koh D, Kim J, Hatano M, Jeon B,
et al. Reciprocal negative regulation between the tumor suppressor protein p53 and B cell CLL/lymphoma 6 (BCL6) via control of caspase-1 expression. J Biol Chem. 2019;294:299-313
pubmed 出版商 Fauster A, Rebsamen M, Willmann K, César Razquin A, Girardi E, Bigenzahn J,
et al. Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ. 2019;26:1138-1155
pubmed 出版商 Zhao L, Zhang B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep. 2017;7:44735
pubmed 出版商 Lafont E, Kantari Mimoun C, Dráber P, De Miguel D, Hartwig T, Reichert M,
et al. The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death. EMBO J. 2017;36:1147-1166
pubmed 出版商 Iurlaro R, Püschel F, León Annicchiarico C, O Connor H, Martin S, Palou Gramón D,
et al. Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors. Mol Cell Biol. 2017;37:
pubmed 出版商 Hartwig T, Montinaro A, von Karstedt S, Sevko A, Surinova S, Chakravarthy A,
et al. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2. Mol Cell. 2017;65:730-742.e5
pubmed 出版商 Dimberg L, Towers C, Behbakht K, Hotz T, Kim J, Fosmire S,
et al. A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance. Mol Cancer Res. 2017;15:382-394
pubmed 出版商 Seo B, Min K, Woo S, Choe M, Choi K, Lee Y,
et al. Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP. Antioxid Redox Signal. 2017;27:215-233
pubmed 出版商 Park S, Jwa E, Shin S, Ju E, Park I, Pak J,
et al. Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage. Int J Biochem Cell Biol. 2017;83:47-55
pubmed 出版商 Weyhenmeyer B, Noonan J, Würstle M, Lincoln F, Johnston G, Rehm M,
et al. Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide. Oncotarget. 2016;7:61295-61311
pubmed 出版商 Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355
pubmed 出版商 Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9
pubmed 出版商 Liesche C, Venkatraman L, Aschenbrenner S, Grosse S, Grimm D, Eils R,
et al. Death receptor-based enrichment of Cas9-expressing cells. BMC Biotechnol. 2016;16:17
pubmed 出版商 Crowder R, Dicker D, El Deiry W. The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death. J Biol Chem. 2016;291:5960-70
pubmed 出版商 Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015;236:43-59
pubmed 出版商 Braun F, Mathur R, Sehgal L, Wilkie Grantham R, Chandra J, Berkova Z,
et al. Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis. PLoS ONE. 2015;10:e0117994
pubmed 出版商 Sullivan E, Jeha S, Kang G, Cheng C, Rooney B, Holladay M,
et al. NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease. Clin Cancer Res. 2014;20:5986-94
pubmed 出版商 Labovsky V, Martinez L, Davies K, Garcia Rivello H, Calcagno M, Matas A,
et al. Association between ligands and receptors related to the progression of early breast cancer in tumor epithelial and stromal cells. Clin Breast Cancer. 2015;15:e13-21
pubmed 出版商 Lee D, Lee C, Kim D, Ae J, Lee T. Digitoxin sensitizes glioma cells to TRAIL-mediated apoptosis by upregulation of death receptor 5 and downregulation of survivin. Anticancer Drugs. 2014;25:44-52
pubmed 出版商 Moriwaki K, Shinzaki S, Miyoshi E. GDP-mannose-4,6-dehydratase (GMDS) deficiency renders colon cancer cells resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor- and CD95-mediated apoptosis by inhibiting complex II formation. J Biol Chem. 2011;286:43123-33
pubmed 出版商 Wenisch S, Trinkaus K, Hild A, Hose D, Heiss C, Alt V,
et al. Immunochemical, ultrastructural and electrophysiological investigations of bone-derived stem cells in the course of neuronal differentiation. Bone. 2006;38:911-21
pubmed
